Needham & Company maintains a 'Hold' on Hi Tech Pharmacal (NASDAQ: HITK).

Analyst, Elliot Wilbur, said, "Despite another very ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE